Skip to main content
. 2020 Mar 26;125(1):e130–e139. doi: 10.1016/j.bja.2020.02.018

Table 1.

Characteristics of study population by intraoperative ventilatory frequency. Data are expressed as n (%), mean (standard deviation), or median (inter-quartile range [25th–75th percentile], values separated by comma). ∗Score for Prediction of Postoperative Respiratory Complications. ED95 dose of neuromuscular blocking agents (NMBA): median effective dose required to achieve a 95% reduction in maximal twitch response from baseline. Fio2, fraction of inspired oxygen; PEEP, positive end-expiratory pressure; PIP, peak inspiratory pressure; Spo2, peripheral oxygen saturation.

Characteristics Group 1
(n=24 392)
Group 2
(n=23 574)
Group 3
(n=28 125)
Group 4
(n=26 541)
Intraoperative ventilatory frequency, median (IQR) 8 (8, 9) 10 (10, 10) 12 (11.5, 12) 15 (14, 18)
Intraoperative ventilatory frequency, range 3–9.75 10–10.75 11–12.25 12.5–43
Age, yr (range) 55.9 (16.8) (18–104) 53.9 (16.3) (18–102) 52.2 (15.9) (18–102) 50.6 (16.2) (18–102)
Sex, male 7312 (30.0) 8966 (38.0) 13 477 (47.9) 12 739 (48.0)
BMI, kg m−2 26.87 (5.7) 28.33 (6.6) 29.58 (7.4) 28.98 (7.2)
ASA physical status classification 2 (2, 3) 2 (2, 3) 2 (2, 3) 2 (2, 3)
ASA ≥3 7826 (32.1) 7933 (33.7) 9954 (35.4) 6928 (26.1)
Emergency surgery 1433 (5.9) 1703 (7.2) 2234 (7.9) 1428 (5.4)
Comorbidities
 Charlson comorbidity index 1 (0, 2) 1 (0, 2) 1 (0, 2) 0 (0, 2)
 History of chronic obstructive pulmonary disease 1093 (4.5) 1153 (4.9) 1379 (4.9) 983 (3.7)
 History of heart failure 948 (3.9) 993 (4.2) 1059 (3.8) 794 (3.0)
 History of smoking 2140 (8.8) 2932 (12.4) 4627 (16.5) 3427 (12.9)
 SPORC score,∗ ≥7 695 (2.8) 702 (3.0) 778 (2.8) 535 (2.0)
 Home oxygen therapy 95 (0.4) 122 (0.5) 151 (0.5) 141 (0.5)
 Respiratory support at home 105 (0.4) 145 (0.6) 173 (0.6) 156 (0.6)
Intraoperative factors
 High-risk surgery 10 548 (43.2) 9803 (41.6) 10 926 (38.8) 7088 (26.7)
 Work relative value units (RVU) 13.99 (7.96, 18.23) 13.99 (8.16, 18.88) 13.18 (7.96, 19.02) 8.57 (5.96, 15.26)
 Duration of surgery, min 124 (83, 180) 127 (86, 186) 129 (85, 195) 87 (52, 144)
 Fluids administered, ml 2500 (2000, 4250) 2500 (2000, 4250) 2500 (2000, 4250) 2125 (1500, 3000)
 Total long-acting opioid dose (oral morphine equivalents), mg 0.00 (0.00, 17.00) 6.80 (0.00, 17.00) 9.00 (0.00, 20.40) 0.00 (0.00, 12.00)
 Total short-acting opioid dose (oral morphine equivalents), mg 37.50 (25.00, 62.50) 37.50 (25.00, 62.50) 31.25 (25.00, 62.50) 25.00 (12.50, 37.50)
 Minimum alveolar concentration of volatile anaesthetics and nitrous oxide 0.99 (0.85, 1.14) 1.00 (0.86, 1.14) 1.00 (0.87, 1.14) 1.01 (0.87, 1.15)
 NMBA ED95 dose, mg 1.76 (0.00, 2.70) 1.83 (0.27, 2.76) 1.79 (0.00, 2.84) 0.00 (0.00, 1.49)
 Neostigmine dose, mg 2.00 (0.00, 3.00) 2.00 (0.00, 3.00) 2.00 (0.00, 3.50) 0.00 (0.00, 0.00)
 Mean arterial pressure <55 mm Hg, min 1 (0, 3) 1 (0, 3) 1 (0, 3) 0 (0, 2)
 Total vasopressor dose, mg 0.00 (0.00, 0.04) 0.00 (0.00, 0.05) 0.00 (0.00, 0.06) 0.00 (0.00, 0.02)
 Packed red blood cell units
 0 23 693 (97.1) 22 975 (97.5) 27 577 (98.1) 26 302 (99.1)
 1 330 (1.4) 264 (1.1) 206 (0.7) 76 (0.3)
 2 251 (1.0) 202 (0.9) 201 (0.7) 81 (0.3)
 ≥ 3 118 (0.5) 133 (0.6) 141 (0.5) 82 (0.3)
Respiratory parameters
 Airway device
 Tracheal tube 21 994 (90.2) 21 847 (92.7) 24 875 (88.4) 9650 (36.4)
 Laryngeal mask airway 2323 (9.5) 1625 (6.9) 3110 (11.1) 16 791 (63.3)
 Combination 75 (0.3) 102 (0.4) 140 (0.5) 100 (0.4)
 Median Fio2, % 54.1 (14.7) 55.4 (14.1) 56.6 (14.0) 55.6 (15.7)
 Median PEEP, cm H2O 2 (2, 5) 3 (2, 5) 4 (2, 5) 2 (2, 5)
 Median PIP, cm H2O 20.5 (5.9) 21.2 (5.9) 21.8 (6.7) 16.2 (8.8)
 Median tidal volume, ml 575 (115) 566 (106) 553 (111) 394 (143)
 Median tidal volume per kg, ml kg−1 9.9 (2.2) 9.5 (2.0) 8.9 (2.0) 6.3 (2.2)
 Median minute volume, L min−1 4.8 (1.0) 5.7 (1.1) 6.5 (1.3) 6.2 (1.9)
 Median end-tidal CO2, mm Hg 34.6 (4.7) 34.8 (4.1) 36.1 (4.7) 40.6 (6.6)
 Spo2/Fio2 ratio 195 (52) 189 (48) 184 (45) 190 (51)
 Non-protective ventilation 11 640 (47.7) 8583 (36.4) 7857 (27.9) 2967 (11.2)